SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Renovis RNVS
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Steve Lokness who wrote (41)10/27/2006 12:54:24 PM
From: John McCarthy  Read Replies (1) of 45
 
FYI
this is the FRX drug .... Desmoteplase

Patient Recruitment for Desmoteplase Phase IIB/III Stroke Study DIAS-2 Placed on Hold
25 Oct 2006

Announced that the Steering Committee of the Phase IIB/III stroke study, DIAS-2, has decided in agreement with the Companies to place patient recruitment temporarily on hold until further data have been analyzed

Message 22949728
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News